Form EFFECT Ensysce Biosciences,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 26, 2026 4:30 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ensysce Biosciences begins final phase of opioid overdose study
- Peptide Tracker Rolls Out Major Update: Honest Adherence Tracking, Smart Injection-Site Rotation, and In-App Vial Reconstitution
- 1933 Industries Reports Third Quarter 2026 Financial Results
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
